Ireland: Firms circle Horizon Therapeutics in potential acquisition [Update]

Horizon Therapeutics, a biopharmaceutical company focused on rare, autoimmune and severe inflammatory diseases, has confirmed that it is engaged in highly preliminary discussions with Amgen, Janssen Global Services, and Sanofi (each a ‘Possible Offeror’) which may or may not lead to an offer being made for the entire share capital of the company.  France-based global…

You must be a HMI Subscriber to view this content.

Subscribe Now »